GTBP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
GT Biopharma Inc (GTBP) is not a strong buy for a beginner, long-term investor at this time. The technical indicators are bearish, the financial performance shows declining trends, and there are no positive catalysts or significant trading trends to support a bullish outlook. The lack of AI Stock Picker and SwingMax signals further reduces confidence in this stock as a good buy right now.
The MACD is below 0 and negatively contracting, indicating bearish momentum. RSI is neutral at 33.709, not signaling oversold or overbought conditions. Moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the stock is trading below key pivot levels, with support at 0.433 and resistance at 0.563.
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
Declining financial performance, including a YoY drop in net income (-4.49%) and EPS (-45.75%). The stock also experienced a -6.61% regular market change, reflecting negative sentiment.
In Q3 2025, revenue remained at 0 with no growth. Net income dropped to -$3,258,000 (-4.49% YoY), and EPS declined significantly to -0.83 (-45.75% YoY). Gross margin remained at 0 with no improvement.
No analyst rating or price target data available.
